Cis-imidazolines as mdm2 inhibitors
CA 2468783 A1 · Owner: Vu, Binh Thanh · Inventors: Liu, Emily Aijun; Kong, Norman; Vu, Binh Thanh
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides compounds according to formula I and formula II and pharmaceutically acceptable salts and esters thereof having the , designations provided herein and which inhibit the interaction of MDM2 protein with a p53-like peptide and have antiproliferative activity (I) (II).
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 9, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 9, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 9, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.